Choice of treatment in operable lung cancer

J R Belcher et al. Br Med J. 1979.

. 1979 May 5;1(6172):1212.

doi: 10.1136/bmj.1.6172.1212.

No abstract available

Similar articles

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer.
Samson P, Waters EA, Meyers B, Politi MC. Samson P, et al. Ann Thorac Surg. 2016 Jun;101(6):2049-52. doi: 10.1016/j.athoracsur.2016.02.086. Ann Thorac Surg. 2016. PMID: 27211932
Choice of treatment in operable lung cancer.
Mantell BS. Mantell BS. Br Med J. 1979 May 26;1(6175):1424. doi: 10.1136/bmj.1.6175.1424-a. Br Med J. 1979. PMID: 445110 Free PMC article. No abstract available.
Fallacy of the five-year survival in lung cancer.
McNeil BJ, Weichselbaum R, Pauker SG. McNeil BJ, et al. N Engl J Med. 1978 Dec 21;299(25):1397-401. doi: 10.1056/NEJM197812212992506. N Engl J Med. 1978. PMID: 714117
[On the choice of an adequate volume of operation on the lymphatic apparatus in lung cancer depending on the tumor localization].
Barchuk AS, Ergnian SM. Barchuk AS, et al. Vestn Khir Im I I Grek. 2007;166(5):111-5. Vestn Khir Im I I Grek. 2007. PMID: 18154109 Review. Russian. No abstract available.
Functional evaluation before lung resection.
von Groote-Bidlingmaier F, Koegelenberg CF, Bolliger CT. von Groote-Bidlingmaier F, et al. Clin Chest Med. 2011 Dec;32(4):773-82. doi: 10.1016/j.ccm.2011.08.001. Clin Chest Med. 2011. PMID: 22054885 Review.